• About Us
  • Disclaimer for Pledge Times
  • T & C
  • Write To Us
Thursday, July 7, 2022
Pledge Times
  • World
  • Business
  • Gaming
  • Tech
  • Entertainment
  • Science
  • Lifestyle
  • Health
  • Sports
  • World
  • Business
  • Gaming
  • Tech
  • Entertainment
  • Science
  • Lifestyle
  • Health
  • Sports
No Result
View All Result
Pledge Times
No Result
View All Result
Home Health

Covid promises spray vaccines via nose or mouth

by admin_l6ma5gus
May 19, 2022
in Health
0
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

The anti-Covid vaccines, developed in ultra-fast times, have avoided deaths, serious illnesses and hospitalizations, as the statistics of all the international health authorities and scientific research suggest, but they could be even better, according to several teams of scientists, and the way to achieve this further advancement could be through the nose. The road is not short, experts admit. But the studies begin to grow. As well as spray vaccine candidates in development (there are 8 nasal vaccines in clinical development and 3 in phase 3 studies, according to the journal Scientific American online). A promise that follows a slower path, but that could be a little closer to the finish line.

“It is the most difficult vaccination, the most complex modality to develop. But the one that would work best”, explains to Adnkronos Salute Mario Clerici, professor of immunology at the University of Milan and scientific director of the Don Gnocchi Foundation. Where are we at? Among the works evaluating this approach there is a recent one, published in ‘Science Translational Medicine’ and visible online, in which a team of scientists explains how an anti-Covid vaccine administered by mouth or nose can help raise the barrier against contagion from Sars-CoV-2. The authors define it as a viable strategy, capable of reducing both disease and airborne transmission. The article reports the results of an animal test with an adenoviral vector vaccine candidate. There is a need for vaccines that also act as a barrier to transmission, especially with the advent of variants – and Omicron sub-variants, such as 4 and 5 – increasingly contagious.

See also  Covid, the study on patients with severe asthma

The international media also devote focus to the topic, one of the most recent is the one that in the ‘New York Times’ hosts the intervention of a scientist, Akiko Iwasaki, at the head of a group from Yale University that works precisely on this: a new approach vaccination with systemic vaccines that train the immune response of the whole body, followed by boosters administered directly into the nasal cavity, to provide special protection in the part of the body most affected by Sars-CoV-2 infection.

“Ideally a nasal vaccine – explains the expert – could enter the mucus layer inside the nose and help the body to produce antibodies that capture the virus before it has a chance to attach itself to people’s cells. By capturing the virus itself. at the site of infection, antibodies induced by nasal vaccines can give an advantage in the fight against “SARS-CoV-2″ by acting before it causes symptoms. ” These vaccines, Iwasaki continues, “can establish highly protective memory B cells and memory T cells.”

See also  SSN: Milanese, "We are proposing a cooperative method to discuss the future of the health system with institutions"

A study just made available on the ‘BioRxiv’ platform, signed by German scientists, sought to compare different approaches to vaccination, evaluating the potential differences in systemic and mucosal immunity conferred by different vaccines and different vaccine regimens that mix various types of shield products. . The various options were tested in hamsters and all regimens containing the live attenuated vaccine candidate sCPD9, which is administered intranasally, showed superior efficacy.

The robust immunity elicited was evident in a wide range of immune parameters, from rapid viral clearance to strong systemic and mucosal humoral responses and rapid recall of memory T cells from lung tissue. show that the use of live attenuated vaccines can offer advantages over available Covid-19 vaccines, particularly when applied as a booster “after a primary course, is the conclusion of the experts.

“The key point – comments Clerici – is that the virus enters through the respiratory mucous membranes. With a nasal vaccine, the vaccine compound is brought in place and the presence of IgA antibodies is stimulated. Which are mucosal, they cover the tissues of the upper respiratory tract. and prevent the virus from coming into contact with them. Therefore the virus does not enter the body. To give another example, a high concentration of vaginal IgA protects against HIV infection with heterosexual transmission “.

See also  Cancer, Italian oncologists on Lancet: "Immunotherapy is not the Holy Grail"


#Covid #promises #spray #vaccines #nose #mouth

admin_l6ma5gus

admin_l6ma5gus

Related Posts

Covid, today’s July 7 bulletin: 107,240 new cases and 94 deaths

by admin_l6ma5gus
July 7, 2022
0

from Silvia Morosi Data for Thursday 7 July. Hospitalizations (+332) and intensive (+18) are on the rise. 28.35% positivity rate...

Covid today Italy, 107,240 infections and 94 deaths: July 7 bulletin

by admin_l6ma5gus
July 7, 2022
0

I'm 107,240 new infections from Coronavirus in Italy today, 7 July 2022, according to Covid data and numbers - region...

Rheumatologist Matucci Cerinic: ‘Systemic sclerosis multiorgan pathology’

by admin_l6ma5gus
July 7, 2022
0

"Systemic sclerosis is a rare systemic disease that affects internal organs, especially of the heart, lung, kidneys, the gastrointestinal tract...

Covid, Ema: “New wave, Omicron 4-5 dominant by the end of the month”

by admin_l6ma5gus
July 7, 2022
0

"We are seeing a new wave" of Covid infections "in many EU states. The spread of the infection is driven...

Covid, developed a new rapid test: identifies variants in a few hours

by admin_l6ma5gus
July 7, 2022
0

from Cristina Marrone Dallas researchers have developed a new exam based on eight regions of the viral genome that can...

Gyrus enters the capital of Consulcesi Group

by admin_l6ma5gus
July 7, 2022
0

"Our goal is to build the largest and most advanced digital platform in the healthcare and pharma industry and Gyrus...

Next Post

HBO Max presents the first look at the Velma series | EarthGamer

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

United States Nasa is setting up a team to investigate unexplained weather phenomena in the United States

3 weeks ago

Opening Women’s Tournament 2022: this is how the first date will be played

4 months ago

Popular News

    • About Us
    • Disclaimer for Pledge Times
    • T & C
    • Write To Us
    Call us: +1 234 JEG THEME
    No Result
    View All Result
    • World
    • Business
    • Science
    • Entertainment
    • Gaming
    • Movie
    • Music
    • Sports
    • Fashion
    • Lifestyle
    • Tech
    • Health

    © 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.